Introduction: Chronic venous insufficiency (CVI) in the lower extremities is a widely observed disease in society. In these patients, endovenous laser ablation (EVLA) treatment, which has been considered highly effective and minimally invasive since 2001, is used in addition to other treatments. In this method, thermal ablation is created by intervention under ultrasound imaging (USG) guidance on the veins identified with color Doppler ultrasonography (CDUS) to have insufficiency. Within a short period, irreversible damage is induced in the vein, leading to autoinhibition and the alleviation of CVI symptoms. Hospitalization is not required for the patient, and they can mobilize with elastocompressive support.
Methods: Our study included 50 patients (89 veins, 71 legs) who were diagnosed with chronic venous insufficiency and classified according to the CEAP (Clinical-Etiology-Anatomy-Pathophysiology) classification between March 2008 and August 2009. Patients who did not have contraindications for EVLA were included. The procedure was performed using a device with a 980 nm wavelength and a 400-micron fiber-optic tip. Additionally, patients with a high number of varices underwent complementary treatment with sclerotherapy targeting superficial veins.
Results: During the five to twenty months of clinical and Doppler follow-ups, among the 89 veins subjected to laser treatment, permanent complete occlusion was observed in 87%, symptomatic recanalization in 6.5%, and asymptomatic recanalization in 6.5%. Procedure-related major complications occurred in 3 patients, and minor complications occurred in 45 patients.
Conclusion: Excluding patients with symptomatic recanalization, the treatment success rate was accepted as 94.5%, consistent with the literature. Consequently, in this prospective study, EVLA was found to be an effective, safe, and advantageous method in terms of patient comfort, rapidly replacing surgery in the treatment of CVI.